Beuschlein F - Search Results

1

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network; Hammer GD, Giordano TJ, Verhaak RGW. Zheng S, et al. Among authors: beuschlein f. Cancer Cell. 2016 May 9;29(5):723-736. doi: 10.1016/j.ccell.2016.04.002. Cancer Cell. 2016. PMID: 27165744 Free PMC article.

2

Clonal composition of human adrenocortical neoplasms.

Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B. Beuschlein F, et al. Cancer Res. 1994 Sep 15;54(18):4927-32. Cancer Res. 1994. PMID: 7915195

3

Steroidogenic acute regulatory protein mRNA expression in adrenal tumours.

Zenkert S, Schubert B, Fassnacht M, Beuschlein F, Allolio B, Reincke M. Zenkert S, et al. Among authors: beuschlein f. Eur J Endocrinol. 2000 Mar;142(3):294-9. doi: 10.1530/eje.0.1420294. Eur J Endocrinol. 2000. PMID: 10700725

4

ACTH-receptor expression, regulation and role in adrenocortial tumor formation.

Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M. Beuschlein F, et al. Eur J Endocrinol. 2001 Mar;144(3):199-206. doi: 10.1530/eje.0.1440199. Eur J Endocrinol. 2001. PMID: 11248736 Review.

5

Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms.

Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M. Schubert B, et al. Among authors: beuschlein f. Clin Endocrinol (Oxf). 2001 May;54(5):627-32. doi: 10.1046/j.1365-2265.2001.01253.x. Clin Endocrinol (Oxf). 2001. PMID: 11380493

6

Discerning malignancy in adrenocortical tumors: are molecular markers useful?

Wachenfeld C, Beuschlein F, Zwermann O, Mora P, Fassnacht M, Allolio B, Reincke M. Wachenfeld C, et al. Among authors: beuschlein f. Eur J Endocrinol. 2001 Sep;145(3):335-41. doi: 10.1530/eje.0.1450335. Eur J Endocrinol. 2001. PMID: 11517015

7

Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1.

Babu PS, Bavers DL, Beuschlein F, Shah S, Jeffs B, Jameson JL, Hammer GD. Babu PS, et al. Among authors: beuschlein f. Endocrinology. 2002 Feb;143(2):665-73. doi: 10.1210/endo.143.2.8658. Endocrinology. 2002. PMID: 11796523

8

Ectopic pro-opiomelanocortin syndrome.

Beuschlein F, Hammer GD. Beuschlein F, et al. Endocrinol Metab Clin North Am. 2002 Mar;31(1):191-234. doi: 10.1016/s0889-8529(01)00025-1. Endocrinol Metab Clin North Am. 2002. PMID: 12055989 Review.

9

Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy.

Beuschlein F, Mutch C, Bavers DL, Ulrich-Lai YM, Engeland WC, Keegan C, Hammer GD. Beuschlein F, et al. Endocrinology. 2002 Aug;143(8):3122-35. doi: 10.1210/endo.143.8.8944. Endocrinology. 2002. PMID: 12130578

10

SF-1, DAX-1, and acd: molecular determinants of adrenocortical growth and steroidogenesis.

Beuschlein F, Keegan CE, Bavers DL, Mutch C, Hutz JE, Shah S, Ulrich-Lai YM, Engeland WC, Jeffs B, Jameson JL, Hammer GD. Beuschlein F, et al. Endocr Res. 2002 Nov;28(4):597-607. doi: 10.1081/erc-120016972. Endocr Res. 2002. PMID: 12530669 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

493 results

Search Page